Exclusive Enteral Nutrition in Adult Crohn’s Disease: an Overview of Clinical Practice and Perceived Barriers

References

• Castiglione F, Imperatore N, Testa A, et al. One-year clinical outcomes with biologics in Crohn’s disease: transmural healing compared with mucosal or no healing. Aliment Pharmacol Ther. 2019;49(8):1026–1039. doi:10.1111/apt.15190
   PubMed Web of Science ®Google Scholar
• Nardone OM, Manfellotto F, D’Onofrio C, et al. Lactose intolerance assessed by analysis of genetic polymorphism, breath test and symptoms in patients with inflammatory bowel disease. Nutrients. 2021;13(4):1290. doi:10.3390/nu13041290
   Web of Science ®Google Scholar
• Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021;18(1):56–66. doi:10.1038/s41575-020-00360
   PubMed Web of Science ®Google Scholar
• Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014;20(1):91–99. doi:10.3748/wjg.v20.i1.91
   PubMed Web of Science ®Google Scholar
• Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008;105(43):16731–16736. doi:10.1073/pnas.0804812105
   PubMed Web of Science ®Google Scholar
• De Sire R, Talocco C, Petito V, et al. Microbiota and inflammatory bowel disease: an update. Recenti Prog Med. 2018;109(12):570–573. doi:10.1701/3082.30741
   PubMedGoogle Scholar
• Britton GJ, Contijoch EJ, Mogno I, et al. Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice. Immunity. 2019;50(1):212–224. doi:10.1016/j.immuni.2018.12.015
   PubMed Web of Science ®Google Scholar
• Lopetuso LR, Ianiro G, Allegretti JR, et al. Fecal transplantation for ulcerative colitis: current evidence and future applications. Expert Opin Biol Ther. 2020;20(4):343–351. doi:10.1080/14712598.2020.1733964
   PubMed Web of Science ®Google Scholar
• Nardone OM, de Sire R, Petito V, et al. Inflammatory bowel diseases and sarcopenia: the role of inflammation and gut microbiota in the development of muscle failure. Front Immunol. 2021;12:694217. doi:10.3389/fimmu.2021.694217
   PubMed Web of Science ®Google Scholar
• Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s disease. Lancet. 2017;389(10080):1741–1755. doi:10.1016/S0140-6736(16)31711-1
   PubMed Web of Science ®Google Scholar
• Geyl S, Guillo L, Laurent V, D’Amico F, Danese S, Peyrin-Biroulet L. Transmural healing as a therapeutic goal in Crohn’s disease: a systematic review. Lancet Gastroenterol Hepatol. 2021;6(8):659–667. doi:10.1016/S2468-1253(21)00096-0
   PubMed Web of Science ®Google Scholar
• Calabrese E, Rispo A, Zorzi F, et al. Ultrasonography tight control and monitoring in crohn’s disease during different biological therapies: a Multicenter Study. Clin Gastroenterol Hepatol. 2021;26. doi:10.1016/j.cgh.2021.03.030
   Google Scholar
• Shafer LA, Walker JR, Chhibba T, et al. Health Care Indicators of Moderate to Severe IBD and Subsequent IBD-Related Disability: a Longitudinal Study. Inflamm Bowel Dis. 2019;25(12):1996–2005. doi:10.1093/ibd/izz102
   Web of Science ®Google Scholar
• Testa A, Rispo A, Romano M, et al. The burden of anaemia in patients with inflammatory bowel diseases. Dig Liver Dis. 2016;48(3):267–270. doi:10.1016/j.dld.2015.10.012
   Google Scholar
• Levine A, Wine E, Assa A, et al. Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial. Gastroenterology. 2019;157(2):440–450. doi:10.1053/j.gastro.2019.04.021
   PubMed Web of Science ®Google Scholar
• Ruemmele FM, Veres G, Kolho KL, et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J Crohns Colitis. 2014;8(10):1179–1207. doi:10.1016/j.crohns.2014.04.005
   PubMed Web of Science ®Google Scholar
• Sandhu BK, Fell JM, Beattie RM, et al. Guidelines for the management of inflammatory bowel disease in children in the United Kingdom. J Pediatr Gastroenterol Nutr. 2010;50(Suppl 1):S1–13. doi:10.1097/MPG.0b013e3181c92c53
   PubMed Web of Science ®Google Scholar
• Forbes A, Escher J, Hébuterne X, et al. ESPEN guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017;36(2):321–347. doi:10.1016/j.clnu.2016.12.027
   PubMed Web of Science ®Google Scholar
• Ashton JJ, Gavin J, Beattie RM. Exclusive enteral nutrition in Crohn’s disease: evidence and practicalities. Clin Nutr. 2019;38(1):80–89. doi:10.1016/j.clnu.2018.01.020
   PubMed Web of Science ®Google Scholar
• Wall CL, Gearry RB, Day AS. Treatment of Active Crohn’s Disease with Exclusive and Partial Enteral Nutrition: a Pilot Study in Adults. Inflamm Intest Dis. 2018;2(4):219–227. doi:10.1159/000489630.
   Google Scholar
• Shukla D, Purcell L, Palmer M, Pillay L. Exclusive enteral nutrition for the treatment of adult Crohn’s disease. J Crohns Colitis. 2020;14(1):S041–S041. doi:10.1093/ecco-jcc/jjz203.040
   Google Scholar
• Gassull MA, Fernández-Bañares F, Cabré E, et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn’s disease: results of a double blind randomised multicentre European trial. Gut. 2002;51(2):164–168. doi:10.1136/gut.51.2.164
   Web of Science ®Google Scholar
• Pigneur B, Garnier-Lenglin H, Lepage P, et al. Effect of exclusive enteral nutrition on the course of CD and intestinal microbiota. J Crohns Colitis. 2014;8(2):S433. doi:10.1016/S1873-9946(14)50135-3
   Web of Science ®Google Scholar
• Alhagamhmad MH. Enteral Nutrition in the Management of Crohn’s Disease: reviewing Mechanisms of Actions and Highlighting Potential Venues for Enhancing the Efficacy. Nutr Clin Pract. 2018;33(4):483–492. doi:10.1002/ncp.10004
   Web of Science ®Google Scholar
• Grover Z, Muir R, Lewindon P. Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn’s disease. J Gastroenterol. 2014;49(4):638–645. doi:10.1007/s00535-013-0815-0
   Web of Science ®Google Scholar
• Bannerjee K, Camacho-Hübner C, Babinska K, et al. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr. 2004;38(3):270–275. doi:10.1097/00005176-200403000-00007
   Web of Science ®Google Scholar
• Fell JM, Paintin M, Arnaud-Battandier F, et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn’s disease. Aliment Pharmacol Ther. 2000;14(3):281–289. doi:10.1046/j.1365-2036.2000.00707.x
   Web of Science ®Google Scholar
• Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K. Impact of elemental diet on mucosal inflammation in patients with active Crohn’s disease: cytokine production and endoscopic and histological findings. Inflamm Bowel Dis. 2005;11(6):580–588. doi:10.1097/01.mib.0000161307.58327.96
   PubMed Web of Science ®Google Scholar
• Guo Z, Gong J, Li Y, et al. Mucosal MicroRNAs Expression Profiles before and after Exclusive Enteral Nutrition Therapy in Adult Patients with Crohn’s Disease. Nutrients. 2016;8(8):519. doi:10.3390/nu8080519
   Web of Science ®Google Scholar
• de Jong NS, Leach ST, Day AS. Polymeric formula has direct anti-inflammatory effects on enterocytes in an in vitro model of intestinal inflammation. Dig Dis Sci. 2007;52(9):2029–2036. doi:10.1007/s10620-006-9449-x.
   Web of Science ®Google Scholar
• Meister D, Bode J, Shand A, Ghosh S. Anti-inflammatory effects of enteral diet components on Crohn’s disease-affected tissues in vitro. Dig Liver Dis. 2002;34(6):430–438. doi:10.1016/s1590-8658(02)80041-x
   PubMedGoogle Scholar
• Nahidi L, Corley SM, Wilkins MR, et al. The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based analysis. Genes Nutr. 2015;10(5):479. doi:10.1007/s12263-015-0479-x
   Web of Science ®Google Scholar
• Graziani C, Talocco C, De Sire R, et al. Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities. Eur Rev Med Pharmacol Sci. 2019;23(2):795–810. doi:10.26355/eurrev_201901_16894
   Web of Science ®Google Scholar
• Wu XX, Huang XL, Chen RR, et al. Paeoniflorin Prevents Intestinal Barrier Disruption and Inhibits Lipopolysaccharide (LPS)-Induced Inflammation in Caco-2 Cell Monolayers. Inflammation. 2019;42(6):2215–2225. doi:10.1007/s10753-019-01085-z
   PubMed Web of Science ®Google Scholar
• Zeissig S, Bürgel N, Günzel D, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease. Gut. 2007;56(1):61–72. doi:10.1136/gut.2006.094375
   PubMed Web of Science ®Google Scholar
• Heller F, Florian P, Bojarski C, et al. Interleukin-13 Is the Key Effector Th2 Cytokine in Ulcerative Colitis That Affects Epithelial Tight Junctions, Apoptosis, and Cell Restitution. Gastroenterology. 2005;2:550–564. doi:10.1016/j.gastro.2005.05.002
   Google Scholar
• Ghosh SS, Wang J, Yannie PJ, Ghosh S. Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development. J Endocr Soc. 2020;4(2):bvz039. doi:10.1210/jendso/bvz039
   PubMed Web of Science ®Google Scholar
• Sanderson IR, Boulton P, Menzies I, Walker-Smith JA. Improvement of abnormal lactulose/rhamnose permeability in active Crohn’s disease of the small bowel by an elemental diet. Gut. 1987;28(9):1073e6. doi:10.1136/gut.28.9.1073
   Web of Science ®Google Scholar
• Nahidi L, Day AS, Lemberg DA, Leach ST. Differential effects of nutritional and non-nutritional therapies on intestinal barrier function in an in vitro model. J Gastroenterol. 2012;47(2):107–117. doi:10.1007/s00535-011-0471-1.
   Web of Science ®Google Scholar
• Nahidi L, Leach ST, Mitchell HM, et al. Inflammatory bowel disease therapies and gut function in a colitis mouse model. Biomed Res Int. 2013;2013:909613. doi:10.1155/2013/909613
   Web of Science ®Google Scholar
• de Sire A, de Sire R, Petito V, et al. Gut-Joint Axis: the Role of Physical Exercise on Gut Microbiota Modulation in Older People with Osteoarthritis. Nutrients. 2020;12(2):574. doi:10.3390/nu12020574
   PubMed Web of Science ®Google Scholar
• Lane ER, Zisman TL, Suskind DL. The microbiota in inflammatory bowel disease: current and therapeutic insights. J Inflamm Res. 2017;10:63–73. doi:10.2147/JIR.S116088
   PubMed Web of Science ®Google Scholar
• Frank DN, Robertson CE, Hamm CM, et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17(1):179–184. doi:10.1002/ibd.21339
   PubMed Web of Science ®Google Scholar
• Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104(34):13780–13785. doi:10.1073/pnas.0706625104
   PubMed Web of Science ®Google Scholar
• Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13(9):R79. doi:10.1186/gb-2012-13-9-r79
   PubMed Web of Science ®Google Scholar
• Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe. 2014;15(3):382–392. doi:10.1016/j.chom.2014.02.005
   PubMed Web of Science ®Google Scholar
• Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004;53(5):685–693. doi:10.1136/gut.2003.025403
   PubMed Web of Science ®Google Scholar
• Li J, Butcher J, Mack D, Stintzi A. Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(1):139–153. doi:10.1097/MIB.0000000000000215
   PubMed Web of Science ®Google Scholar
• MacLellan A, Moore-Connors J, Grant S, Cahill L, Langille MGI, Van Limbergen J. The Impact of Exclusive Enteral Nutrition (EEN) on the Gut Microbiome in Crohn’s Disease: a Review. Nutrients. 2017;9(5):447. doi:10.3390/nu9050447
   Web of Science ®Google Scholar
• Di Caro S, Fragkos KC, Keetarut K, et al. Enteral Nutrition in Adult Crohn’s Disease: toward a Paradigm Shift. Nutrients. 2019;11(9):2222. doi:10.3390/nu11092222
   Web of Science ®Google Scholar
• Escuro AA, Hummell AC. Enteral Formulas in Nutrition Support Practice: is There a Better Choice for Your Patient? Nutr Clin Pract. 2016;31(6):709–722. doi:10.1177/0884533616668492
   Web of Science ®Google Scholar
• Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2007;2(1):CD000542. doi:10.1002/14651858.CD000542.pub2
   Web of Science ®Google Scholar
• Verma S, Brown S, Kirkwood B, Giaffer MH. Polymeric versus elemental diet as primary treatment in active Crohn’s disease: a randomized, double-blind trial. Am J Gastroenterol. 2000;95(3):735–739. doi:10.1111/j.1572-0241.2000.01527.x
   Web of Science ®Google Scholar
• Grafors JM, Casswall TH. Exclusive enteral nutrition in the treatment of children with Crohn’s disease in Sweden: a questionnaire survey. Acta Paediatr. 2011;100(7):1018–1022. doi:10.1111/j.1651-2227.2011.02178.x
   Web of Science ®Google Scholar
• Van Rheenen PF, Aloi M, Assa A, et al. The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update. J Crohns Colitis. 2020;2020:jjaa161. doi:10.1093/ecco-jcc/jjaa161
   Web of Science ®Google Scholar
• Dziechciarz P, Horvath A, Shamir R, Szajewska H. Meta-analysis: enteral nutrition in active Crohn’s disease in children. Aliment Pharmacol Ther. 2007;26(6):795–806. doi:10.1111/j.1365-2036.2007.03431.x
   PubMed Web of Science ®Google Scholar
• Whitten KE, Rogers P, Ooi CY, Day AS. International survey of enteral nutrition protocols used in children with Crohn’s disease. J Dig Dis. 2012;13(2):107–112. doi:10.1111/j.1751-2980.2011.00558.x.
   PubMed Web of Science ®Google Scholar
• Yang Q, Gao X, Chen H, et al. Efficacy of exclusive enteral nutrition in complicated Crohn’s disease. Scand J Gastroenterol. 2017;52(9):995–1001. doi:10.1080/00365521.2017.1335770
   PubMed Web of Science ®Google Scholar
• Yang Q, Tang J, Ding N, et al. Twelve-week peptide-based formula therapy may be effective in inducing remission of active Crohn disease among women who are pregnant or preparing for pregnancy. Nutr Clin Pract. 2021. doi:10.1002/ncp.10733.
   Web of Science ®Google Scholar
• Sharma S, Gupta A, Kedia S, et al. Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease. Intest Res. 2021;19(3):291–300. doi:10.5217/ir.2019.09172
   Web of Science ®Google Scholar
• Xu Y, Guo Z, Huang L, et al. A nomogram for predicting the response to exclusive enteral nutrition in adult patients with isolated colonic Crohn’s disease. Therap Adv Gastroenterol. 2019;11(12):1756284819881301. doi:10.1177/1756284819881301
   Web of Science ®Google Scholar
• Narula N, Dhillon A, Zhang D, Sherlock ME, Tondeur M, Zachos M. Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2018;4(4):CD000542. doi:10.1002/14651858.CD000542.pub3
   PubMed Web of Science ®Google Scholar
• Guo Z, Wu R, Zhu W, et al. Effect of exclusive enteral nutrition on health-related quality of life for adults with active Crohn’s disease. Nutr Clin Pract. 2013;28(4):499–505. doi:10.1177/0884533613487218
   Web of Science ®Google Scholar
• Mitrev N, Huang H, Hannah B, Kariyawasam VC. Review of exclusive enteral therapy in adult Crohn’s disease. BMJ Open Gastroenterol. 2021;8(1):e000745. doi:10.1136/bmjgast-2021-000745
   Web of Science ®Google Scholar
• Mutsekwa RN, Edwards JT, Angus RL. Exclusive enteral nutrition in the management of Crohn’s disease: a qualitative exploration of experiences, challenges and enablers in adult patients. J Hum Nutr Diet. 2021;34(2):440–449. doi:10.1111/jhn.12829
   Web of Science ®Google Scholar
• Navas-López VM, Martín-de-carpi J, Segarra O, et al. PRESENT; PREScription of Enteral Nutrition in pediaTric Crohn’s disease in Spain. Nutr Hosp. 2014;29(3):537–546. doi:10.3305/nh.2014.29.3.7184
   Web of Science ®Google Scholar
• Wall CL, McCombie A, Mulder R, Day AS, Gearry RB. Adherence to exclusive enteral nutrition by adults with active Crohn’s disease is associated with conscientiousness personality trait: a sub-study. J Hum Nutr Diet. 2020;33(6):752–757. doi:10.1111/jhn.12787.
   Web of Science ®Google Scholar